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ABSTRACT 
Transcatheter treatments for coarctation of the aorta include balloon angioplasty and stent implantation. How-
ever, balloon angioplasty has its limitations and may be associated with complications, such as, recoarctation, 
dissection, and aneurysm formation, in adult patients. Bare metal stent implantation has offered an alternative 
during the last decade or so, but covered stents have been used with increasing frequency more recently, to the 
extent that covered stent implantation is the preferred treatment in correctly selected patients. Primary stent 
insertion, whether bare metal or covered, prevents elastic recoil of the aorta and may provide better and more pre-
dictable results than balloon angioplasty. Furthermore, stents are preferable for the treatment of complex aortic 
arch obstructions, but their usage is limited to older patients, because of limitations associated with growth. (Korean 
Circ J 2009;39:261-263) 
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Aortic coarctation has a wide morphological spec-
trum that varies from transverse arch and isthmal hy-
poplasia, which are seen most commonly in newborn 
infants, to discrete stenosis or membrane like obstruc-
tions just beyond the left subclavian artery, which are 
typically observed in older patients. Occasionally tubu-
lar hypoplasia affects a long segment of the thoracic aor-
ta. Blood pressure control can be improved in adult pa-
tients after relieving the stenosis, and thus, despite age 
at presentation, coarctation of the aorta must be add-
ressed to improve long-term outlook.
1) 
The techniques of surgical repair of aortic coarcta-
tion include excision of the obstruction and end-to-
end anastomotic repair, and on occasions, patch repair 
or even the insertion of a tube bypass graft when the 
anatomy is more complex. In older patients, surgery 
can be challenging, and complications include spinal 
cord damage, pleural effusion, paradoxical hypertension, 
and infection.
2)3)  
Balloon dilation was the earliest form of non-surgi-
cal intervention adopted, and was first used in 1982.
4) 
However, even now the technique has its opponents, 
because histological data shows that successful relief of 
stenosis is accompanied by damage to the aortic intima 
and media, which are difficult to control. In addition, 
in adult patients, a markedly tortuous aortic segment 
may involve the coarctation or aortic wall thinning, and 
cystic medial necrosis may be present.
5) In older patients, 
calcification of the aorta may also be present. Accor-
dingly, these factors may predispose adult patients to 
dissection and aneurysm formation or even rupture. 
Because of these many concerns, bare metal stents 
were used to avoid dissection or over-dilation or elastic 
recoil of the aorta. Stenting may result in less vascular 
injury than balloon angioplasty alone.
6) Stents also tack 
intimal flaps to the wall of the aorta, which allows heal-
ing to occur without causing intimal dissection, and which 
reinforces weakened areas. Moreover, this combination 
of factors could reduce the incidence of aneurysm for-
mation. Stents were first used in 1991 to treat aortic co-
arctation and have become the procedure of choice in 
many institutions.
7) However, after obtaining good ini-
tial results with stents, a residue of important compli-
cations remained, such as, aneurysm formation. It was 
considered that these complications were due to the full 
dilatation of tight coarctations with a stent in a single 
procedure, and thus, the technique was modified to re-
duce the incidence of aneurysm formation. This mo-
dification involved partially inflating a stent during an 
initial procedure to 60-70% of its planned final dia-
meter, and redilating it fully 6-12 months after initial 
implantation.
8)9) However, in cases of bare metal stent-
ing, complications, such as, aneurysm formation, stent 
malposition, and vascular complications, occur even af-
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ter making these modifications, although death and 
the need for emergency surgery are rare.
10)11) Despite a 
lack of data in the literature, acute procedural results 
indicate that stenting produces more predictable results 
and is safer than balloon angioplasty. Furthermore, the 
stenting of aortic coarctations is effective at achieving 
acute and sustained reductions in blood pressure gra-
dients. Usually a residual obstruction is caused by un-
suspected transverse arch hypoplasia. Complications, 
such as, deaths may occur in 0-1.4% of cases after stent-
ing, and neurological damage in 0-3.7%, although the 
vast majority of studies have reported no neurological 
damage following treatment. Aneurysm formation oc-
curs in 0-17% of cases after bare metal stenting, but 
stent fracture is uncommon and is usually of no clini-
cal significance. Other complications during stent in-
sertion may be related to vascular access, and include 
avulsion, stenosis at the entry site, false aneurysm for-
mation, thrombosis, stent migration, balloon rupture, 
paradoxical hypertension, and endocarditis.
10)11) On the 
other hand, although neo-intimal proliferation may oc-
cur, it is rarely a significant problem.   
A variety of covered stents are available for clinical 
use in Europe. These include the covered Cheatham-
Platinum stent, the Jomed covered stent, the recently 
commercialized Atrium stent, and various stent grafts 
used to treat atherosclerotic aneurysms of the aorta.
12) 
The covered stent most commonly used to treat aortic 
coarctation is the covered Cheatham-Platinum stent.
13-15) 
This stent has been used as a rescue treatment in patients 
with aneurysms or with previous stent-related compli-
cations, or as primary treatment in patients with an 
elevated risk of developing complications due to a com-
plex anatomy (e.g., near interruption or a tortuous 
aortic arch), or in patients beyond the third decade.
16-19) 
In many cases, covered stents also tend to be dilated to 
about 70% during the first procedure, and no attempt 
is made to match the stent to the dilated aorta by fl-
aring. Nevertheless, in the region of the coarctation, a 
covered stent should be apposed to the aortic wall.   
Additional indications for covered stent placement 
include adult patients with a localised or long-segment 
native aortic coarctation, aortic recoarctation after pre-
vious treatment, aneurysms that have previously un-
dergone surgical or interventional treatment, and pa-
tients with coarctation associated with a patent arterial 
duct.
20-23) Furthermore, in patients with a long affected 
segment or a near atretic coarctation, covered stents can 
be implanted safely with good results.
24)25) One study 
reported on nine patients, in whom, indications for co-
vered stenting included; a tight or atretic native coarc-
tation, an age of over 50 years of age, a patent arterial 
duct, an aneurysm, or a fractured previously implanted 
stent.
26) In two patients over 35 years of age with an an-
eurysmal ascending aorta, aneurysm formation was as-
cribed to implanted stents at follow up. 
Covered stents cannot be substantially re-expanded, 
and thus, should be avoided in growing children, but 
in one study, stents were re-dilated 6 months after in-
itial under-dilation and residual gradients were aboli-
shed. However, in one of the four patients involved, a 
stent fractured and the implantation of another cover-
ed stent was required.
24) Butera et al.
27) also demonstrat-
ed the feasibility of re-dilating covered stents in 7 child-
ren at a mean 20 months after initial implantation. No 
complications were encountered. 
Dissection or rupture of the aorta is an important 
indication for the need for re-implantation, and thus, 
covered stents should be available for bail-out purposes. 
However, it is noteworthy that aortic rupture can occur 
even with implantation of stents.
28)29) 
Covered stents have also been used to treat pseudo-
aneurysms which form after the conventional stenting 
of an aortic coarctation.
30) Kenny et al.
31) used both 
self-expanding and balloon-expandable covered stents 
to treat aortic coarctation in 37 patients aged from 9 
to 65 years, and encountered aortic rupture in one pa-
tient. However, few reports are available that address 
the use of covered stents as a primary treatment for co-
arctation, rather than for aneurysm formation. In a 
study of 22 patients, one patient required a further 
covered stent because of rupture of the aortic wall.
29) 
Nevertheless, it is encouraging that no report has been 
issued on aneurysm formation after covered stent place-
ment.  
The use of covered stents presents the risk of spinal 
cord injury due to possibility of occlusion of spinal ar-
teries, although these arise well below the level of coar-
cation, usually at the level of T9-12 vertebrae. Further-
more, clinical anxieties related to spinal cord injury due 
to covered stents are not substantiated by the literature 
on the stent grafting of distal atherosclerotic aortic 
aneurysms, during which considerable segments of the 
aorta are covered, and for which the risk of spinal cord 
damage appears to be 1-4%.
32) 
Covering the origin of the subclavian artery may be 
of concern, although ideally a reasonable distance be-
tween the origin of the subclavian artery and the site 
of coarctation is needed, in many patients the left sub-
clavian artery is too close to the coarctation and co-
vering its origin cannot be avoided. Surgical data from 
patients in whom the subclavian artery is used as a flap, 
and thus sacrificed, and recent experience with stent-
graft implantation for distal aortic disease, which inva-
riably involves covering the origin of the left subclavian 
artery, suggest that complications are rare. Neverthe-
less, ischaemia of the right arm has been reported in 
an adult patient, in whom an anomalous origin of the 
right subclavian artery was covered intentionally with a 
stent graft, which was implanted because of false an- 
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eurysm formation after repair of an aortic coarctation. 
In this case, the ischaemic arm was treated conservati-
vely and symptoms improved.
33) 
Indications for the use of covered stents to treat aor-
tic coarctation and its related complications are wide 
ranging and continue to expand. Indeed in adults, co-
vered stents may be considered the primary treatment 
of choice for native aortic coarctation.   
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